Company intelligence / Profile preview
Interactome Biotherapeutics
Grand Rapids, Michigan, United Statesinteractomebio.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Interactome Biotherapeutics has demonstrated in preclinical studies that its lead candidate IB001 enhances neural immune function, increases axonal outgrowth, boosts neural mitochondria activity, and induces anti-inflammatory signaling. The company’s engineered exosome technology enables efficient delivery of diverse therapeutic payloads. No clinical trial results are yet available; the company remains at the IND-enabling/preclinical stage with anticipated value inflection points in mid–2025.
- Therapeutic areas
- CardiovascularRare DiseasesNeurology
- Modalities
- Engineered small extracellular vesicles (sEV/exosomes)Secretome-based biologicsNanoparticle drug delivery (including nucleic acids, proteins/peptides, small molecules, aptamers)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Henry Ford InnovationsOxford University Innovation—technology partnerships shaping company advancements.Non-dilutive funding from Bristol Myers Squibb.
Beyond the preview
Go deeper on Interactome Biotherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Interactome Biotherapeutics.